View Older Stories View More Recent Stories

Mar 13, 2019 08:34AM Agenus (AGEN) Secures $7.5M Milestone Payment from Gilead Sciences, Inc. (GILD)
Mar 13, 2019 08:30AM Agenus Milestone Triggers $7.5M Payment from Gilead
Mar 8, 2019 09:00AM Agenus to Report Fourth Quarter and Full Year 2018 Financial Results on March 14, 2019 and Host Conference Call and Webcast
Feb 19, 2019 08:30AM Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare
Feb 15, 2019 11:41AM Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019
Jan 29, 2019 08:00AM Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare
Jan 29, 2019 08:00AM Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc.
Jan 24, 2019 08:30AM Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead
Jan 9, 2019 10:30AM Selexis Expands Strategic Immuno-Oncology Alliance with Agenus
Jan 3, 2019 11:30AM Agenus Awarded Grant to Enable QS-21 Innovations
Dec 20, 2018 08:28AM Agenus (AGEN), Gilead Sciences, Inc. (GILD) Announces Collaboration to Develop Immuno-Oncology Therapies
Dec 20, 2018 07:30AM Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies
Dec 20, 2018 07:30AM Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies
Nov 13, 2018 04:05PM Agenus Elects New Board Member Dr. Allison Jeynes-Ellis and Appoints Chief Operating Officer Dr. Jennifer Buell
Nov 13, 2018 11:30AM Agenus to Present at the 2018 Jefferies London Healthcare Conference
Nov 6, 2018 05:42PM Agenus to Present Data on Neoantigen Vaccines and anti-CD137 Antibody at SITC 2018
Nov 6, 2018 07:30AM Agenus Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Oct 31, 2018 09:23AM Agenus to Report Third Quarter 2018 Financial Results on November 6, 2018 and Host Conference Call and Webcast
Oct 22, 2018 06:21AM Agenus (AGEN) Reports Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018
Oct 20, 2018 07:30AM Agenus Presents Clinical Data on Its PD-1 & CTLA-4 at ESMO 2018
Oct 9, 2018 09:00AM Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018
Sep 28, 2018 08:38AM Agenus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY
Sep 21, 2018 07:04AM Agenus (AGEN) Closes $15 Million Partial Royalty Monetization With XOMA (XOMA)
Sep 21, 2018 07:00AM Agenus Closes $15 Million Partial Royalty Monetization With XOMA
Sep 17, 2018 09:03AM Agenus (AGEN) Secures $5M Milestone Payment from Incyte (INCY) for Initiation of Phase 1 Clinical Trial of INCAGN2385
Sep 17, 2018 09:00AM Agenus Receives Milestone Payment from Incyte
Sep 5, 2018 07:34PM AgenTus Therapeutics to Present on the Anti-tumor Activities of Two Proprietary T Cell Receptors (TCRs) at CAR-TCR Summit in Boston, MA
Sep 4, 2018 09:57AM Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City
Aug 9, 2018 08:00AM Agenus Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Feb 14, 2017 07:07AM Incyte (INCY), Agenus (AGEN) Announce Amendment to Collaboration Agreement
Feb 14, 2017 07:00AM Incyte and Agenus Amend Collaboration Agreement
Jan 17, 2017 09:00AM Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
Oct 26, 2016 02:46PM Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
Oct 14, 2016 08:30AM Cancer Immunotherapy ETF Celebrates One-Year Anniversary
Jan 21, 2016 09:28AM Pre-Open Stock Movers 01/21: (ZFGN) (XLNX) (FEYE) Higher; (OGXI) (ALKS) (SLM) Lower (more...)
Oct 26, 2015 02:16PM Trading Radar for 10/26: Apple (AAPL), Twitter (TWTR), Alibaba (BABA), Comcast (CMCSA), Pfizer (PFE) Report
Oct 20, 2015 07:00AM Agenus to Report Third Quarter 2015 Financial Results on October 27, 2015; Conference Call to Follow
Sep 9, 2015 07:00AM Agenus Inc. Completes $115 Million Non-Dilutive Royalty Transaction with Oberland Capital
Sep 8, 2015 10:00AM Agenus to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
Jul 24, 2015 01:08AM GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
Jul 23, 2015 07:00AM Agenus Reports Second Quarter 2015 Financial Results
Jul 20, 2015 07:00AM Agenus Acquires Novel Antibodies to Immuno-oncology Target CEACAM1
Jul 16, 2015 04:00PM Agenus to Report Second Quarter 2015 Financial Results on July 23, 2015; Conference Call to Follow
Jun 22, 2015 05:41PM Agenus to Webcast Annual Meeting of Stockholders
Jun 18, 2015 03:15PM Agenus to Present at the 2015 JMP Securities Life Sciences Conference
Jun 17, 2015 07:00AM Agenus Appoints C. Evan Ballantyne as Chief Financial Officer
Jun 3, 2015 07:00AM Merck Extends Immuno-Oncology Collaboration with Agenus
May 14, 2015 07:00AM Agenus Announces Oral Presentation at ASCO Highlighting Improved Survival with Prophage Immunotherapy in Brain Cancer Compared to Historical Controls
May 8, 2015 07:00AM Agenus to Host Research and Development Day on May 14, 2015
Apr 28, 2015 07:00AM NEJM Publishes Study Showing GSK’s Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Adjuvant Provides over 97% Protection in People Over the Age of 50
View More Recent Stories View Older Stories